Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
can't believe were up 35% and were at 16 cents, my god these crooks should be thrown in jail
yeah was hoping something in biosights pipeline because not much catalyst on our side, thanks
so after the last 1/15 rs which killed so many of us, and if a proposed 10-30 rs votes in and were reduced again is there any possible news that would propel such a low float to pop, or give us a chance to exit before they do an offering again? any hope with merk ? thanks
so just came back from Aruba and received email for proxy vote today, did everyone get this, ? believe 4 proposals and 1 is for reverse split to tune of 1/10 to 1/30? also if they don't get the votes another proposal is to adjourn meeting until they have the votes? isn't this what Berlin attempted to do and failed and when that subsequently failed at proxy he then went into the proposed reverse merger? thinking were screwed here no matter how vote comes down? thoughts
otc, but i'm sure Berlin who believe is still ceo will just do a 15 or 20/1 rs and keep a float
maybe s-4 was filed but really nothing that we didn't already know
lmao! although I prefer the queen on GOT with her walk of shame in all her beauty
so nothing has changed, day late and a dollar short, seems over the years the trials grew slower, the patients for trial consistently drew lower numbers and eventually cervical, neo, etc all get swept up as being too little to late, shame!
thanks, can only hope for something positive
include me and whats worse is I kept adding thinking the science would win out over the repeated blunders and because as we all experienced Berlin would shaft us with multiple toxic offerings and rs's, man if I could go back in time.....
If I can remember that long ago think we were around 7-9 bucks and had a pending cervical in the eu? not to mention an amgen 400m partnership for neo?
Iggy, that frugalness will certainly change if Berlin is ceo in my opinion, would of been more excited if there was a revamping of ceo, and bod. etc... and take my chances with new and fresh leadership and a new focus on trials and strategy, time will tell
so if after completed merger adxs and their share holders will own 25% of new company then my question is why the hell would they keep Berlin as ceo? lets be honest here since Ken took over he's lost, abandoned, or scrapped multiple most promising vaccines and therapies, cervical, lost neo and Amgen, etc... with toxic financings and killer r/s's, i'm all for merger, gives me slight hope but why Berlin? This is very hard to accept going forward
so just got home from work and saw adxs up 23% and read its a reverse merger, does anyone know if number of shares stays the same or if they are still contemplating an rs? thanks
so folks we need everyone to leave the room because of a water main break, then all the suit cases come out from under the desks and rs is approved? lmao
really hate it when people are so politically correct these days, you should really try to say whats on your mind lol
me too, better yet why aren't they fired? need an Alex Dinner activist type to swoop in and take over like he did when I had Ariad, get rid of the trash and replace with quality people, oh I forgot Denner was here and was smart enough to bail about 4 years ago, lol
I would agree, my point is if the bums are tossed and proxy fails it may finally open the door for a partnership or a buy out and close the door on reverse splits followed by toxic offerings, and that scenario would have to be better than continuation of status quo
I can think of one more, buyout! maybe not great terms for longs but certainly better than where we are at currently, remember what PTBarnum said
nickwvt, when we ran to 1.50's few months back I was the one who posted we needed 20 consecutive days not 10 to regain compliance because of the extensions granted by nasdaq and I at the time was somewhat rejected or questioned, wish I was wrong on that
so I voted no on everything except the accountant, have been here for years and must say i'm shocked that apparently rs is defeated, retail doesn't have the votes so some big names must of had enough, perhaps a take over, partnership,(which we had with neo only to lose) or a buyout will now be on the table, longs are screwed here but perhaps some potential new investors waiting on asco poster presentations won't be swallowed up and be stuck here, as always hope for the best but expect the worst
I am not qualified but wonder if variables changed such as dosing, frequency, and observations etc... more troubling is how the hell we ever going to be taken serious from future potential partners if all we got is 9 patients? brutal
so just got home to see a high volume move but can't find any reason for it , have to get back to work would appreciate it someone has any reliable news to share, thanks
so I just voted no or against on every single item except the accounting firm, wish to go up about 130M more shares and want permission for another RS, so you know its coming
James, any idea on how many patients? thanks
is it their company or are they partnering? not sure how to read this
so Lo just gave a rehash of what we already knew except he did say they have submitted pk protocol to fda and are awaiting feedback so they can then proceed with pk study and resubmission plans, again said 2 partners that are un named are very big and want their molecule and partnership a secret for now because they are in a very competitive field and believe this could give them a leg up over competition using zsans micro needle, all sounds good but we need money
huh? need to re read what I said, stated zsan has regained compliance after 20 some odd days, never said adxs has, but was wondering about the 10 or 20 day rule, nickwt seemed to answer that
seems to be ambiguity with nasdaq compliance rules and extensions granted under the pandemic. I own shares of both adxs and zsan and can tell you zsan had and still counting over 24 straight days over 1 yet just received notice from nasdaq as now being compliant and 8k stipulated 20 straight days which is why I brought this to attention of board, I hope adxs gets compliant news otherwise Berlin may very well do what we longs fear
that doesn't seem probable, not if you believe the 8-k zsan released couple weeks back. pk protocol hopefully submitted to fda by end of march, fda will review and give guidance or announce changes to protocol(which is great news, seems they want this approved) then pk study would begin, once study is completed I would think results submitted back to fda if everything looks good, remember this high plasma was with only 5 patients, then fda could give us a new pudfa date, i'm hoping worst case by years end and would love it quicker, hopefully lo's presentation on 9th will shed some light
so now we have compliance and it stated 20 straight days and i'm hearing rumblings that if you asked for an additional 180 days nasdaq could then double the consecutive days from 10-20 but never found a link, Lo needs cash to not only fund cluster and new pk study but all operations so he needs to get cash in a non dilutive way, grants for covid or hopefully just 1 of 3 partners actually come forward with indication and money or if he has nothing he will do another offering, its that simple, prey for partner
Iggy, just relaying my own experience with zsan, we all wrote countless emails to nasdaq and zosano asking wtf was going on and why were still listed as deficient and of course no response and then yesterday came compliancy and 20 consecutive days stated in letter, remember we were issued a crl back 10/22 and asked for an additional 180 days so this could be relevant
is there any truth that if you were non compliant and asked for a 180 day extension and nasdaq granted such an extension then you would now need 20 consecutive days to being over 1 not old threshold of 10 days? Zsan made 10 days on 2/17 and have been over 1 since yet only yesterday received compliance notice and stated 20 consecutive days in letter, Adxs was only 11 days starting on 2/5 to 2/22 and since been under 1, don't have link of such a rule but if true not good for Adxs
NO, not from zsan or nasdaq, matter of fact zsan has never responded and probably sent 5-6 emails over last 2.5 years, their pr dept. for lack of a better word is crap
well that clears all that up, nothing released for 3 years if ever and because study in complete hard to draw a conclusion, thanks for finding that
I would never try to figure out whats going on in Berlin brain, my take, I am not sure how long it would take to assemble all the data between years of trials and patients and with Petit and others bailing do they even have the personnel and money to get it done? I would agree that if I knew results were stellar and I were in charge you can bet your ass they would be out
my take was we pulled out of EU approval, continued with trial because Berlin was concerned about gaining approval, then talked about shutting down aim11 because of cost all the while engaging in NEO and starting up with Hot, and his talking of shutting down aim led directly to our sp plunging and the start of many toxic financings, but no where have I ever thought it was shut down because of horrible results, no such evidence of that, more based on endless cash being spent with no end in sight. however until data is released your guess is as good as anyone elses here, its a guess!
So its been over 2 weeks now of being nasdaq compliant yet still were listed as deficient, what the hell is zsan doing? wrote to their pr dept. asking for an answer, also sent one to nasdaq totaly unacceptable
Blue, we had a paying partner for Neo and they bailed, then we had some money to conduct trials, bad management and spreading us to thin killed us then , so with not much money or employees and I believe too few patients to gather meaningful data what the hell can be done to get Merck or others to pony up, get some skin in the game ?
So we are nasdaq compliant yet no official word, happened a week ago, we have 4 partners, Eversana and Mitsubishi and 2 new undisclosed partners, J&J is getting approval for their single dose vaccine and these vaccines were approved in record time for emegency use under Trumps operation warp speed, last night zsan received patent protection and also listed on patent is J&J, who Zsan was spun out of just a few years back, so while we wait for our pk study for migraine approval wouln't it be something if J&J or any of the 3 partners have been working and testing our micro needle patch with their vaccine, and perhaps we get the same emergency use approval! perhaps a long shot $$$$